Treating gastric cancer cell lines (AGS and MKN4) with SFN led to the decreased proliferation, apoptosis induction, and reduced expression of miRNA-9 and miRNA-326, and thereby, SFN enhanced levels of CDX1 and CDX2 in AGS and MKN4 [48]. This evidence concerns the gene CDX2 and gastric cancer.